4
Changes in Ownership
Eledon Pharmaceuticals, Inc. Filed Acc 0001562180-15-001098
Options or other derivatives
- Chief Operating Officer acquired 62,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| McBride John S. Chief Operating Officer | 2015-12-15 | Grant or award · Stock Option (right to buy) | +62,000 | 62,000 | D | ||
Loading xslF345X03/primarydocument.xml…